, although most of the LcrG remains cell associated. In the present study, we showed that the cell-associated LcrG is cytoplasmically localized. We demonstrated that LcrG interacts with LcrV to form a heterodimeric complex by using chemical cross-linking and copurification of LcrG and LcrV. Additionally, we found that small amounts of LcrV and YopE can be detected in periplasmic fractions isolated by cold osmotic shock and spheroplast formation, indicating that their secretion pathway is accessible to the periplasm or to these procedures for obtaining periplasmic fractions. We propose that the cytoplasmically localized LcrG blocks the Yop secretion apparatus from the cytoplasmic side and that LcrV is required to remove the LcrG secretion block to yield full induction of Yop and LcrV secretion and expression.
Yersinia pestis, the causative agent of plague, has a plasmidencoded low-calcium response (LCR) regulatory mechanism that governs the expression and secretion of a set of virulence proteins in response to environmental conditions (9, 47) . In vitro, the secreted Yops (Yersinia outer proteins) and V antigen (also called LcrV) are expressed maximally and secreted at 37ЊC in the absence of Ca 2ϩ . In the presence of millimolar concentrations of Ca 2ϩ , their expression is downregulated and their secretion is completely blocked. It has become apparent from tissue culture infection models that the absence of Ca 2ϩ in vitro mimics an unidentified signal that the yersiniae receive when they are adherent to a eukaryotic cell (36, 47) . This signal triggers vectorial translocation of at least some of the Yops into the eukaryotic cell, where they derange cellular signalling and other biochemistry necessary for phagocytosis and the mobilization of an effective immune response (15, 29, 38, 47) . Concomitantly, expression of Yops and LcrV becomes maximally induced. A popular model for the connection between the contact-triggered secretion and the transcriptional upregulation is the secretion of a repressor component by the Yop secretion system (3, 8, 31, 47) . Accordingly, secretion and its regulation are central to the LCR.
Yops and LcrV are secreted without processing by a proprietary Yop secretion system that is encoded by the LCR virulence plasmid (9, 42) . This mechanism, encoded by at least 19 genes, represents a recently recognized class of secretion system termed type III (39) or contact dependent, whose members appear to function for virulence protein secretion in a number of gram-negative animal and plant pathogens (9) . Secretion of all Yops and LcrV appears to be regulated negatively in response to environmental Ca 2ϩ by two proteins, LcrE and LcrG. The secreted protein LcrE (also called YopN) acts at the bacterial surface, presumably as a Ca 2ϩ sensor, although that activity has not been directly demonstrated (13) . LcrG, also secreted, is believed to act in conjunction with LcrE (42) to block secretion of Yops and LcrV in the presence of Ca 2ϩ . Mutations inactivating either LcrE or LcrG cause strongly induced secretion and expression of all Yops and LcrV in vitro at 37ЊC whether Ca 2ϩ is present or absent (13, 36, 42, 43) . Additional proteins, such as LcrQ, YscO, or YscP, appear to modulate the secretion of only a subset of the Yops and LcrV (1, 26, 35) .
LcrV is both an LCR regulatory protein and an antihost protein with strong immunomodulatory effects (3, 23, 43) . LcrV has a quantitative effect on induction of LCR-regulated gene expression, being necessary for full transcriptional induction of the LCR stimulon: in the absence of LcrV, only partial induction occurs in vitro at 37ЊC in the absence of Ca 2ϩ (32, 43) . Analysis of double mutants having defects in lcrV and one of the negative regulatory LCR loci (lcrE or lcrG) led to the conclusion that LcrV does not function directly as an activator, but instead counteracts negative regulation. lcrV Y. pestis mutants are capable of strongly secreting YopM when the protein is expressed independently of LCR regulation, indicating that LcrV is not essential for secretion (43) . This finding, coupled with evidence that it is cytoplasmic rather than secreted LcrV that functions in regulation, prompted the hypothesis that LcrV might act at the level of the LCR repressor (43) . Interestingly, lcrE, but not lcrG, Y. pestis hypersecretes V antigen, leaving little LcrV inside the bacteria, whereas in parental Y. pestis cultures, almost half of the LcrV is located in the soluble cellular fraction (43) . Moreover, mutations in either lcrE or lcrG are epistatic over mutations in lcrV, indicating that LcrV's function is somehow bypassed or irrelevant in lcrE or lcrG backgrounds (43) and suggesting that LcrV, LcrE, and LcrG function in the same pathway. These findings suggest that LcrV interacts in some way with LcrE and LcrG.
The present study was undertaken initially as separate investigations of the regulatory roles of LcrG and LcrV in the LCR. We report evidence that these two proteins directly interact to form a stable complex and describe localization experiments that determine the likely sites of action of LcrG and its complex with LcrV.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Y. pestis strains used were KIM5 (from R. R. Brubaker ; 31]. For genetic manipulations (e.g., transformation, isolation of plasmid DNA), Y. pestis strains were grown in heart infusion broth or on tryptose blood agar base medium (Difco Laboratories, Detroit, Mich.) at 26ЊC. Growth of Y. pestis for physiological studies was conducted in a defined medium, TMH, as previously described (45) . Briefly, Y. pestis cultures were grown in exponential phase at 26ЊC with shaking at 200 rpm for about eight generations, and final cultures to be harvested were initiated at 26ЊC at an A 620 of ca. 0.1. When the A 620 reached ca. 0.2, the temperature was shifted to 37ЊC, and incubation was continued for 6 h before cells were harvested. Escherichia coli strains used were GM2163 (51) and DH5␣ (Gibco BRL, Grand Island, N.Y.). E. coli strains were grown in LB broth or on LB agar plates (10) . Streptomycin and ampicillin, both at 100 g/ml (Sigma Chemical, St. Louis, Mo.), were used to supplement the various media as appropriate. pHTV is a plasmid that was constructed to overexpress a polyhistidine-tagged LcrV fusion protein (HTV) having 19 residues (including 6 His residues) fused to the N terminus of LcrV (12) . HTV is expressed from the pProEX-1 vector (Gibco BRL) under control of the strong trc promoter and was induced during growth at 37ЊC with 0.1 to 0.5 mM isopropyl-␤-D-galactopyranoside (IPTG; Sigma) in both E. coli and Y. pestis. Plasmid pTL61T (20) was used to provide expression of ␤-galactosidase and ␤-lactamase, used for quality control in studies to localize LcrG. pES6-1 (43) contains the HindIII G fragment of the Y. pestis KIM5 LCR plasmid pCD1 and encodes intact LcrG, LcrV, LcrH, and YopB. Plasmid pGST-G (see below) in E. coli DH5␣ grown at 37ЊC was used to overexpress a glutathione S-transferase-LcrG fusion protein (GST-G) for purification of LcrG. GST-G expression was induced by addition of 1 mM IPTG when the culture A 620 had reached ca. 0.8. Incubation of the culture was continued for an additional ca. 3 h before cells were harvested. Plasmids pAraG18K (expressing LcrG), pAraV18K (expressing LcrV), and pAraGV18K (expressing both LcrG and LcrV) were constructed (see below) to express LcrG and LcrV under control of the araBAD promoter. pTT4, containing lcrE under control of the tac promoter (12) (see below), was used to overexpress LcrE in the YopD Ϫ Yersinia pseudotuberculosis III (pIB15) (from Hans Wolf-Watz, University of Umeå, Umeå, Sweden). Cultures in TMH lacking added Ca 2ϩ were grown at 26ЊC to A 620 of 0.4. The temperature was shifted to 37ЊC, and incubation was continued to allow the culture A 620 to reach 0.8. IPTG was added to 0.1 mM, and incubation was continued for 5 or 6 h before the culture supernatant was harvested.
DNA methods. Plasmid DNA was isolated by an alkaline lysis method (4), by the method of Kado and Liu (17) , or by the use of Qiagen columns (Qiagen, Inc., Studio City, Calif.). Cloning methods were essentially as described previously (40) . DNA fragments were isolated from agarose gels by using the Qiaex DNA purification kit (Qiagen). Electroporation of DNA into E. coli, Y. pestis, and Y. pseudotuberculosis was done as described previously (28) . To construct pTT4 (12) , lcrE was obtained from pGP2-1 (30) by cutting at the nonmethylated ClaI site upstream of lcrE, filling in with Klenow fragment, and cutting downstream (in the multiple cloning site of the pBluescript II SKϪ vector [Stratagene, La Jolla, Calif.]) with BamHI. This fragment was cloned into SmaI-and BamHI-cut pTTQ8 (44) and electroporated into E. coli DH5␣ for preliminary characterization and then into Y. pseudotuberculosis III(pIB15). pGST-G was constructed by cloning a BamHI-and EcoRI-cleaved PCR fragment containing lcrG into BamHI-and EcoRI-cleaved pGEX-3X (Pharmacia Biotech, Piscataway, N.J.). Primers for the PCR were as follows: upstream, 5Ј-CTA TGG ATC CTA ATG AAG TCT TCC CAT TTT-3Ј; downstream, 5Ј-AGC GTG AAT TCA TTA AAT AAT TTG CCC TCG CAT-3Ј. The template was pES6-1. The PCR reaction used the GeneAmp PCR reagent kit (Perkin Elmer Cetus, Norwalk, Conn.) according to the manufacturer's protocol, and the product was generated with 30 cycles at 94ЊC for 1 min, 37ЊC for 2 min, and 68ЊC for 2 min in a Perkin Elmer Model 480 thermocycler. Correctness of the fusion junction was verified by sequencing of double-stranded DNA (with sequence-specific primers) by the dideoxy-chain termination method (41) using the Sequenase 2.0 sequencing kit (United States Biochemical Corp., Cleveland, Ohio) and [␣- 35 S]dATP from New England Nuclear Corp. (Boston, Mass.). Plasmids pAraG18K, pAraV18K, and pAraGV18K were constructed by cloning a BamHI-and EcoRI-cleaved PCR product into pBAD18-Kan (14) . Primers used were AraG-Start (5Ј-GGA ATT CAG GAG GAA ACG ATG AAG TCT TCC CAT TTT GAT-3Ј) and AraGStop (5Ј-CGC GGA TCC TTA AAT AAT TTG CCC TCG-3Ј) to make pAraG18K, AraV-Start (5Ј-GGA ATT CAG GAG GAA ACG ATG ATT AGA GCC TAC GAA-3Ј) and AraV-Stop (5Ј-CGC GGA TCC TTA TCA TTT ACC AGA CGT GTC-3Ј) to make pAraV18K, and AraG-Start and AraV-Stop to make pAraGV18K. The PCR was performed as above except for the cycling profile, which was 30 cycles at 94ЊC for 15 . Cellular extracts were made by disintegration of bacteria in a French press (20,000 psi). Low-speed centrifugation (8,000 ϫ g, 10 min) removed unbroken cells and large debris. Total soluble proteins (cytoplasmic plus periplasmic) were separated from membranes by ultracentrifugation at 417,000 ϫ g for 15 min in a TLA100.4 rotor or at 513,000 ϫ g in a TLA120.2 rotor for 10 min, using a Beckman Optima TLX ultracentrifuge. The top 10 ml of ca. 20 ml of culture supernatant from Y. pestis grown in TMH medium at 37ЊC was removed without disturbing the cell pellet, and total proteins were precipitated with 5% (vol/vol) trichloroacetic acid (TCA) for 2 h to overnight on ice. After centrifugation (14,000 ϫ g for 30 min) to pellet the precipitated proteins, the pellet was neutralized with 15 (2) , and stored at Ϫ20ЊC.
Periplasmic fractions were isolated from Y. pestis by two methods: conversion to spheroplasts (46) and cold osmotic shock (25) . (i) For formation of spheroplasts, cells corresponding to 10 A 620 units ⅐ ml were suspended in 1 ml of ice-cold Tris-sucrose buffer (25% [wt/vol] sucrose, 10 mM Tris [pH 7.8]). Spheroplasts were made by incubation for 5 min at room temperature with lysozyme (0.5 mg/ml) followed by rapid addition of 2 ml of 15 mM Na 2 EDTA (pH 7.5). Incubation was continued at room temperature until spheroplasts were evident by light microscopy (ϳ5 min). The spheroplasts were recovered by centrifugation (8,000 ϫ g for 10 min), and the supernatant containing periplasmic proteins was retained. Periplasmic proteins released from the formation of spheroplasts, secreted proteins in the original culture supernatant, and proteins from the spheroplasts were concentrated with TCA as described above. (ii) For cold osmotic shock, Y. pestis cells corresponding to 10 A 620 units ⅐ ml were harvested and resuspended in 1 ml of Tris-sucrose-EDTA buffer (30 mM Tris-Cl, 20% [wt/vol] sucrose, 1 mM Na 2 EDTA [pH 8.0]) and incubated for 10 min at room temperature with gentle agitation on a rocker platform. The cells were harvested by centrifugation (8,000 ϫ g for 10 min), rapidly resuspended in 1 ml of ice-cold 5 mM MgSO 4 , and then incubated on ice with shaking for 10 min. The cellular fraction was separated from the periplasmic fraction by centrifugation (8,000 ϫ g for 10 min), and the periplasmic, culture supernatant, and shocked-cell fractions were concentrated with TCA as described above.
HTV was purified from E. coli and Y. pestis soluble protein extracts by metal chelation chromatography using a nickel-nitrilotriacetic acid (Ni-NTA) column (Qiagen) and following the manufacturer's protocol. GST-G from E. coli overexpressing the fusion protein was purified on a glutathione column (Pharmacia). GST-G was then digested with factor Xa protease (Boehringer Mannheim Biochemicals, King of Prussia, Pa.) and passed over the glutathione column a second time to obtain LcrG. Although this procedure removed most of the free GST, some nonetheless was not removable by the glutathione column, despite repeated passages, and remained in the final LcrG preparation. LcrG was obtained from Y. pestis by antibody affinity chromatography. An anti-LcrG (␣-LcrG) antibody column was made by cross-linking a rabbit polyclonal antibody specific for LcrG (see below) to protein A-Sepharose (Sigma) (ϳ2 mg of antibody to 1 ml of wet beads) as previously described (16) . Antibodies were allowed to bind to protein A by incubation in PBS overnight with shaking at 4ЊC. Next, crosslinking was done after washing the beads twice with 10 volumes of 0.2 M Na borate buffer (pH 9.0) by incubation for 30 min at room temperature with 20 mM dimethylpimelimidate (Sigma) in 0.2 M Na borate (pH 9.0). The cross-linking reaction was stopped by washing the beads in 0.2 M ethanolamine (pH 8.0) followed by incubation for 2 h at room temperature as described previously (16) . The beads were washed once with PBS, and noncovalently bound antibody was eluted with 100 mM glycine (pH 3.0) followed by final equilibration with PBS. Y. pestis soluble protein extracts were passed over this column, followed by 20 column volumes of PBS and a preelution wash with 10 column volumes of 10 mM sodium phosphate buffer (pH 6.8) prior to elution of the bound protein. Bound LcrG was eluted with acidic 100 mM glycine (pH 3.0) into tubes containing 1 M Na 2 HPO 4 (pH 8.0) to neutralize the acidic glycine. All protein concentrations were measured by using the bicinchoninic acid assay (Pierce Chemical, Rockford, Ill.).
Antibody reagents. Two ␣-LcrV reagents were used: one with reactivity against both LcrG and LcrV (␣-VG) and one specific only for LcrV (␣-HTV) (12) . The entire procedure for generating ␣-GV was described in detail previously (48) . Briefly, a 10-liter culture of Y. pestis KIM5 was grown at 37ЊC in Ca 2ϩ -deficient complex medium (6, 7). LcrV was semipurified from the cell extract of the harvested bacteria by sequential ammonium sulfate precipitation (20% saturation and then 50%), dialyzed, and fractionated by anion-exchange chromatography. Female New Zealand White rabbits were immunized with the semipurified LcrV. Serum samples having reactivity against LcrV were pooled and extensively adsorbed with broken cells of Y. pestis KIM6 (lacking the LCR plasmid) and Y. pestis KIM5-3042 (LcrV Ϫ due to an insert of Mu dI1 [Ap r lac] in upstream lcrG, but overexpressing Yops [27] ). Immunoglobulin G (IgG) was partially purified by ammonium sulfate fractionation followed by dialysis against PBS. ␣-LcrV prepared in this way also had reactivity against LcrG because of the phenomenon reported in this paper: in the cytoplasm LcrV forms a tight complex with LcrG. The adsorption failed to remove the ␣-LcrG reactivity because the bacteria used for adsorption did not express LcrG.
To obtain ␣-LcrE antibody, the proteins in the supernatant from 1-liter cultures of Y. pseudotuberculosis III(pIB15, pTT4) were TCA precipitated and separated in preparative SDS-12% polyacrylamide gels. LcrE was electroeluted from bands that were well separated from other proteins and not contaminated by the similar-sized YopD due to the absence of YopD in the Y. pseudotuberculosis host strain. Antibody was raised in female New Zealand White rabbits as previously described (30) , except that booster doses used LcrE-containing gel pieces that had been ground to a slurry in PBS.
␣-HTV (12) and ␣-GST-G were raised in female New Zealand White rabbits as previously described (30) . Rabbit ␣-␤-galactosidase was obtained from Cooper Biomedical (West Chester, Pa.), and rabbit ␣-␤-lactamase was the generous gift of Kathleen Postle (Washington State University, Pullman, Wash.). IgG was purified on protein A-Sepharose (Sigma) and dialyzed against PBS. Mouse ␣-YopE was the generous gift of Gerard P. Andrews and Arthur M. Friedlander (USAMRIID, Ft. Dietrick, Md.).
Protein electrophoresis and immunodetection. Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), using 12 or 15% (wt/vol) polyacrylamide gels as indicated, according to the method of Laemmli (18) . Samples containing whole cells or membrane fractions were boiled or heated at ca. 95ЊC for 3 to 5 min prior to being loaded on the gels. ␤-Mercaptoethanol was omitted from protein samples that were cross-linked with dithiobis(succinimidyl propionate) (DSP) to preserve the cross-linking. Lanes in which subcellular fractions (soluble, membrane, and secreted proteins) were compared were loaded so as to contain amounts of the fractions derived from the same volume of original culture. Proteins separated by SDS-PAGE were transferred to an Immobilon-P membrane (Millipore Corp., Bedford, Mass.) using carbonate transfer buffer (pH 9.9) (42). Specific proteins (LcrG, LcrV, YopE, LcrE, ␤-galactosidase, and ␤-lactamase) were visualized on the membranes as previously described (30) by using the polyclonal antibodies specific for the proteins and a secondary antibody (goat anti-rabbit or goat anti-mouse; Sigma) conjugated to alkaline phosphatase.
Chemical cross-linking of proteins. Proteins in whole-cell extracts, soluble protein fractions, or cell-free culture supernatants were cross-linked in either PBS or HBS, using ethylene glycolbis(succinimidylsuccinate) (EGS), ethylene glycolbis(sulfosuccinimidyl-succinate) (sulfo-EGS), DSP, bismaleimidohexane (BMH), or disuccinimidyl suberate (DSS) (all purchased from Pierce) as crosslinkers at indicated concentrations for 20 to 30 min at room temperature according to the manufacturer's instructions. After cross-linking, the reactions were quenched by supplying excess primary amines (e.g., Tris-Cl [pH 8 .0] to a 50 to 100 mM final concentration); in the case of BMH, excess sulfhydryl groups (e.g., mercaptoethanol) were added by addition of an equal volume of 2ϫ SDS sample buffer. Optimal concentrations of cross-linkers had to be determined empirically by testing a series of concentrations for each cross-linker and sample type (e.g., whole cultures, cellular extracts or fractions, purified proteins), as the different samples presented different amounts of interfering components (such as primary amino groups) to the cross-linking reaction. For cross-linking cultures of Y. pestis growing in TMH, a sample of culture corresponding to 20 A 620 units ⅐ ml was transferred after ca. 5 h of growth at 37ЊC to a prewarmed 250-ml flask in a shaking water bath and EGS was added to a final concentration of 1, 5, or 10 mM. Cross-linking was allowed to occur for 30 min at 37ЊC before quenching with Tris, added to a final concentration of 50 mM, for 15 min. Cultures were removed to ice and processed with a French press to obtain soluble fractions as described above. All cross-linking experiments using organic-soluble cross-linkers included samples that were mock treated with dimethyl sulfoxide (Sigma) to 10%, which was used as the cross-linker vehicle.
RESULTS

LcrG and LcrV interact with each other.
To further elucidate the regulatory roles of LcrG and LcrV in the LCR, we determined if LcrG and LcrV interacted with other proteins. Soluble extracts from Y. pestis KIM5 or KIM5-3001 grown in the presence or absence of Ca 2ϩ were chemically cross-linked using a variety of commercially available reagents (EGS, sulfo-EGS, DSP, BMH, and DSS). Immunoblots of cross-linked samples that were probed in duplicate blots with ␣-VG (directed against both LcrV and LcrG), ␣-HTV (specific for LcrV), or ␣-GST-G (specific for LcrG) showed a novel band of ϳ48 to 50 kDa in each case (Fig. 1A , visualized for ␣-GST-G in lanes 2 and 4; Fig. 3 shows this band visualized in duplicate blots with ␣-HTV and ␣-GST-G). This band was weakly visible in non-cross-linked samples (Fig. 1A, lanes 1 and 3, Fig. 1B . A homobifunctional amine-reactive cross-linker was added to cell-free soluble protein extracts (A and B) or growing cultures (C). Cross-linked protein samples corresponding to 0.05 A 620 unit ⅐ ml of culture were separated by SDS-PAGE in a 12% gel and analyzed in duplicate immunoblots with ␣-GST-G or ␣-HTV. Data are shown for detection with ␣-GST-G. (A) Lanes 1 and 2, the yersiniae were grown in medium containing Ca 2ϩ ; lanes 3 and 4, the yersiniae were grown in medium without Ca 2ϩ
; lanes 1 and 3, the samples were not cross-linked; lanes 2 and 4, the samples were cross-linked with 3 mM DSP. (B) Lanes 1 to 5, the samples were cross-linked with 0, 1, 3, 6, and 10 mM DSP, respectively. (C) Lanes 1 and 3, the yersiniae were grown in medium lacking Ca 2ϩ ; lanes 2 and 4, the yersiniae were grown in medium containing Ca 2ϩ
; a cross-linker (1 mM EGS) was added to the cultures of lanes 3 and 4 before the soluble cellular fraction was prepared. The position of LcrG is indicated with a dot, and the position of the 48-to 50-kDa complex is indicated with an asterisk. The locations of molecular mass standards are indicated at the left of each panel.
previously in many immunoblots as a "cross-reactive band" (24) . After cross-linking, this band became broadened, perhaps due to having variable numbers of attached cross-linker molecules, and often exhibited weak staining of the part that was densest. Its size of 48 to 50 kDa was consistent with LcrG (ϳ11 kDa) and LcrV (ϳ37 kDa) interacting to form a complex. This band was greatly intensified upon cross-linking (Fig. 1A, lanes  2 and 4, and Fig. 1B ) and was more prominent in yersiniae grown in the absence of Ca 2ϩ than in its presence, suggesting that the appearance of the complex was linked to the LCR. A similar band, similarly Ca 2ϩ regulated in amount, was obtained when growing cultures of Y. pestis KIM5 were subjected to cross-linking (Fig. 1C) . The in vivo result showed that the putative interaction represented by the new band likely reflected an interaction that was occurring in live bacteria and was not an artifact of performing the cross-linking procedure after the bacteria had been taken from LCR-inductive conditions and handled in the cold to obtain cell extracts. Its presence after SDS-PAGE of whole-cell samples or extracts that had not been cross-linked indicated that the interaction was very strong.
Because LcrV-specific and LcrG-specific antibodies detected a complex of similar size, we determined if LcrG and LcrV were interacting. We cross-linked soluble-protein samples from an E. coli strain carrying plasmid pES6-1, which encodes LcrG, LcrV, LcrH, and YopB. Immunoblots of the cross-linked samples from E. coli probed with a mixture of ␣-HTV and ␣-GST-G showed that we could detect the 48-to 50-kDa complex in E. coli ( Fig. 2A) , suggesting that the interacting proteins were encoded on pES6-1. As a control, we introduced pHTV into E. coli to see if HTV could cross-link to any E. coli proteins. HTV did not form a complex in E. coli ( Fig. 2A) , even though HTV can be cross-linked to form the complex in the LcrV Ϫ Y. pestis KIM5-3421 containing pHTV ( Fig. 2A) . This indicates that HTV does not interact with E. coli proteins but does bind to a Y. pestis protein. These results, combined with the size of the complex (48 to 50 kDa) and its visualization with antibodies against LcrG (␣-GST-G) and LcrV (␣-HTV) but not with antibody to LcrH (data not shown) suggest that LcrG (ϳ11 kDa) and LcrV (ϳ37 kDa) can form a heterodimeric complex. To further test the requirement of LcrV to form the 48-to 50-kDa complex, LcrG, LcrV, or both LcrG and LcrV were expressed in E. coli under the control of the arabinose-inducible P BAD promoter. Soluble protein extracts were prepared from E. coli containing the cloning vector (pBAD18-Kan), pAraG18K, pAraV18K, or pAraGV18K and cross-linked with 3 mM DSP. The resulting un-cross-linked and cross-linked samples were analyzed in duplicate immunoblots for visualization of LcrG, using ␣-GST-G (Fig. 2B) , or visualization of LcrV, using ␣-HTV (data not shown). This experiment showed that only when both LcrG and LcrV were coexpressed did the 48-to 50-kDa complex appear when probed with ␣-GST-G (Fig. 2B, lane 8) or ␣-HTV (data not shown). This experiment also allowed us to rule out the possibility that the 48-to 50-kDa complex was composed of only LcrG, as a band of an appropriate size was not seen in crosslinked extracts containing only LcrG (Fig. 2B, lane 4) .
LcrG and LcrV can be copurified. To further substantiate that LcrG and LcrV interact, we determined if they could be copurified. LcrG was purified on resin containing ␣-GST-G: DSP-cross-linked or untreated soluble protein extracts from Y. pestis KIM5 grown in the absence of Ca 2ϩ were applied to the column, and the resulting fractions were analyzed on duplicate immunoblots probed with ␣-GST-G or ␣-HTV (Fig. 3) . LcrG and the 48-to 50-kDa complex were recovered from the column as expected (Fig. 3B, lanes 3 and 6 [no cross-linker] , and lane 9 [with cross-linker], respectively). All or most of the LcrG present in the protein samples was bound by the column, with none appearing in the column flowthrough (Fig. 3B, lanes 2, 5,  8, and 11) . In non-cross-linked samples, LcrV appeared in both the flowthrough (Fig. 3A, lanes 2 and 5) and eluate fractions (Fig. 3A, lanes 3 and 6) , demonstrating that some LcrV could be retained by the ␣-GST-G column, even though ␣-GST-G has no reactivity for LcrV (e.g., see Fig. 3B ). We hypothesized that this LcrV was binding to the LcrG bound on the column. All or most of the LcrG in the Y. pestis extracts, but not all of the LcrV that was present, was retained by the ␣-LcrG column. This shows that LcrV is present in excess when compared to LcrG and raises the possibility that all the LcrG present is capable of interacting with LcrV. Additionally, most or all of the free LcrG chases into the complex after cross-linking with 3 mM or greater concentrations of DSP ( Fig. 1 and 3) . However, the inability to visualize free LcrG could partially be due to blocking of epitopes by DSP and not to the complexing of all of the LcrG with LcrV. To assess the contribution of the cross-linker to visualization of LcrG, we cross-linked Y. pestis soluble-protein fractions from cultures grown in the absence or presence of Ca 2ϩ with various amounts of cross-linker and visualized the complex and the free LcrG with ␣-GST-G (data for absence of Ca 2ϩ illustrated in Fig. 1B ). This experiment showed that our ability to detect the complex was unaffected by concentrations of cross-linker as high as 3 mM, at which concentration all of the free LcrG had disappeared. At 6 mM crosslinker, the band due to the complex appeared slightly more diffuse (more strikingly visible in samples with lower amounts of complex than in Fig. 1B) , and at 10 mM DSP, the amount of complex appeared to decrease, probably due to blockage of epitopes by DSP. Similar results were obtained with another amine-reactive cross-linker, EGS; however, the sulfhydryl-reactive BMH could not chase all free LcrG into the complex even at concentrations as high as 10 mM (data not shown). In the presence of Ca 2ϩ , when there are only small amounts of LcrG and LcrV in the cells, all of the LcrG was bound in the LcrG-LcrV complex at DSP concentrations as low as 1 mM (data not shown). These findings suggest that most or all of the LcrG in the soluble cellular fraction can be cross-linked to LcrV, whereas the reverse is not true (Fig. 3) .
Using the ␣-LcrG affinity column to purify LcrG and the 48-
FIG. 3. LcrV copurifies with
LcrG by ␣-GST-G affinity chromatography, and the isolated complex contains LcrG and LcrV. Soluble-protein extracts, either cross-linked with 3 mM DSP or untreated, from Y. pestis KIM5 grown at 37ЊC without calcium were applied to an ␣-GST-G antibody column. Samples removed from the extracts before application to the column were loaded in lanes 1, 4, 7, and 10, and samples of the flowthrough material were loaded in lanes 2, 5, 8, and 11. After washing, the proteins bound to the column were eluted with 100 mM glycine (pH 3.0) (lanes 3, 6, 9, and 12). Before-column samples corresponded to 0.05 A 620 unit ⅐ ml of the original culture. Samples of flowthrough and elution fractions corresponded to 0.1 A 620 unit/ml of original culture. The samples were separated by SDS-12% PAGE and analyzed in duplicate immunoblots with ␣-HTV (A) or ␣-GST-G (B). Lanes are otherwise identical in panels A and B. Lane 1, before-column sample; lane 2, flowthrough fraction; lane 3, elution fraction; lanes 4 to 6, same as lanes 1 to 3 plus 5% ␤-mercaptoethanol; lanes 7 to 9, same as lanes 1 to 3 plus 3 mM DSP; lanes 10 to 12, same as lanes 7 to 9 plus 5% ␤-mercaptoethanol. The locations of molecular mass standards are indicated at the left of each panel.
to 50-kDa complex allowed us to show that the complex recovered from the column contained LcrG and LcrV. We used the cross-linker DSP in these experiments because it dissociates under reducing conditions, such as the addition of ␤-mercaptoethanol, allowing analysis of the components of the crosslinked complex. Upon reduction of the 48-to 50-kDa complex purified on the ␣-LcrG column (Fig. 3A and B, lanes 9) we were able to recover LcrV (Fig. 3A, lane 12) and LcrG (Fig.  3B, lane 12) , showing that the complex recognized by ␣-GST-G and ␣-HTV contains LcrG and LcrV. We also determined whether the LcrG-LcrV complex would be obtained when cross-linked samples from LcrV Ϫ Y. pestis KIM5-3241 containing pHTV were purified on an Ni-NTA column. As predicted, the LcrG-HTV complex and LcrG copurified along with HTV, even though LcrG alone does not bind to this column (data not shown).
Purified LcrG and LcrV interact in vitro. As a final test for interaction between LcrG and LcrV, we purified HTV and GST-G fusion proteins from E. coli to test whether the purified proteins could interact in vitro. After purification of GST-G, the GST portion was cleaved from the protein with factor Xa and passed over a glutathione column to remove the GST. This removed all but a recalcitrant amount of GST from the preparation. When we mixed these proteins and subsequently cross-linked them with DSS or BMH, we obtained the LcrGLcrV complex (Fig. 4) . This showed that LcrG and LcrV by themselves could interact to form the stable complex, without the involvement of another bacterial protein. For some unknown reason when the purified HTV used in this experiment was probed with ␣-GST-G, the HTV was visualized on a Western blot; however, other batches of purified HTV and HTV in extracts of E. coli or Y. pestis do not cross-react with the antibody (data not shown).
Localization of LcrG and LcrG-LcrV complex. Previous studies had shown that about half of the LcrV and a portion of the LcrG synthesized are secreted by the Yop secretion system (e.g., see references 42 and 43) . This suggested the possibility that the complex might be secreted. As the localization of the complex directs our thinking about its possible function, we carried out localization studies for LcrG and its complex with LcrV. We cross-linked cell-free culture supernatants from Y. pestis grown with or without Ca 2ϩ , using concentrations of the amine-reactive EGS or sulfhydryl-reactive BMH up to 10 mM. The proteins were then recovered by precipitation with TCA and analyzed in immunoblots. We saw LcrG in non-crosslinked (Fig. 5, lane 4) and cross-linked samples and the LcrGLcrV complex in cross-linked samples (Fig. 5, lanes 5 to 7, for LcrG visualization and data not shown for LcrV). These results show that the LcrG-LcrV complex is secreted or can form upon release of LcrG and LcrV into the culture medium. A comparison of the amounts of LcrG in soluble and extracellular fractions showed that the majority of the LcrG and of the complex was in the soluble fraction. Previous work (42) also showed more LcrG in the soluble fraction than in culture supernatants, but the difference did not appear as great as that shown in Fig. 5 (lane 1 versus lane 4 ) because supernatants were more concentrated when analyzed in the earlier studies. In several investigators' hands in our lab and in different experiments done by single individuals, the amount of extracellular LcrG has varied from that shown in with the membrane fraction in the presence than in the absence of Ca 2ϩ (data not shown). We tested whether the amount or distribution of LcrG or the LcrG-LcrV complex obtained after cross-linking was affected by an lcrE mutation. Y. pestis KIM5-3001.6 lcrE, which constitutively expresses and secretes Yops irrespective of the presence of Ca 2ϩ at 37ЊC, resembled the induced parent Y. pestis in expression and localization of LcrG and the complex.
All data implicated the soluble cellular fraction as the location for most LcrG and suggested the soluble cellular fraction as a candidate for LcrG's site of action. However, this fraction in all of our work to date combined proteins from two cellular compartments, the periplasm and the cytoplasm. To determine the source of LcrG in the soluble cellular fraction, we used two different methods of separating cytoplasm from periplasm, cold osmotic shock and the formation of spheroplasts. We used Y. pestis KIM5 carrying the plasmid pTL61T to provide non-LCR regulated control proteins for the cytoplasm (␤-galactosidase) and the periplasm (␤-lactamase). As expected, the bulk of the ␤-lactamase was localized to the periplasm (Fig. 6) , and not unexpectedly, a small amount was present in the cytoplasm. Also as expected, ␤-galactosidase (Fig. 6 ) and the cytoplasmic protein LcrH (also called SycD; data not shown) were found only in the cytoplasm. Regardless of whether we used cold osmotic shock (Fig. 6 ) or spheroplast formation (data not shown), we saw LcrG in the cytoplasmic fraction of the cells and not the periplasm; in these experiments, very little LcrG was in the culture supernatant (not visible in Fig. 6 ). These results show that the soluble cell-associated LcrG is cytoplasmic. Surprisingly, small amounts of LcrV (Fig. 6A) and at least two other Yops, YopE (Fig. 6B) and LcrE (YopN) (Fig. 6C) , were reproducibly found in the periplasmic fraction (although not in the periplasm obtained by spheroplast formation in the case of LcrE [data not shown]); however, YopM and YopH could not be detected in periplasmic fractions (data not shown).
DISCUSSION
In this study, we discovered and characterized an interaction between two LCR regulatory proteins in Y. pestis, the negative regulatory protein LcrG and the bifunctional, positive regulatory and virulence protein LcrV. LcrG and LcrV were found to form a complex of a size likely to contain one molecule of each, and purified complexes could be dissociated to yield LcrG and LcrV. The LcrG-LcrV complex was sufficiently stable to withstand heating in SDS and ␤-mercaptoethanol and subsequent SDS-PAGE, and presumably formed in native protein extracts, as immunoprecipitation with ␣-GST-G of whole-cell extracts not subjected to cross-linking also brought down LcrV (Fig. 3  and reference 50) . However, the LcrG-LcrV complex did mostly dissociate upon SDS-PAGE, and its study was facilitated by cross-linking. A range of homobifunctional crosslinker types was tested and found to work: both aqueous and nonaqueous, with spacer arms ranging from 11.4 to 16.1 Å and having reactivities either for free amino groups (EGS, sulfo-EGS, DSP, and DSS) or sulfhydryl groups (BMH). As LcrG and LcrV each have only one cysteine, stabilization of the complex with BMH implies that these unique cysteines come within ca. 16 Å of each other when LcrG and LcrV interact.
Recently, it was reported that LcrV and LcrH (34) overexpressed from one transcript in E. coli can be copurified and that these proteins interact over a period of many hours in an enzyme-linked immunosorbent assay (21) . Possible sources of copurification are the large-scale preparative protocol used (21) or a fusion protein which we have found is made between LcrV and LcrH when expressed from a single clone in E. coli (12) . lcrV and lcrH are in the same translational frame on their native transcript, and lcrV's termination codon is inefficient in E. coli, resulting in an LcrV-LcrH chimera. We did not find LcrH copurifying with LcrV when the proteins were expressed from separate transcripts in E. coli (12) . Additionally we saw no evidence of an interaction between LcrV and LcrH in the studies reported herein.
The LcrG-LcrV complex was obtained from growing Y. pestis cultures or cellular extracts subjected to cross-linking and after cross-linking cellular extracts from E. coli containing a plasmid encoding LcrG, LcrV, LcrH, and YopB. The LcrGLcrV complex was generated in vitro by combining purified LcrG and HTV and subjecting the mixture to cross-linking. or three minor higher-molecular-weight species (Fig. 1, 3 , and 5), but these did not copurify with the LcrG-LcrV complex in affinity chromatography, and we do not yet know their significance.
The results presented in this paper have allowed the formulation of a revised model for how LcrV and LcrG function in the regulation of the Y. pestis LCR at 37ЊC (Fig. 7) . In the presence of Ca 2ϩ LcrG may directly or indirectly block the secretory machinery from the cytoplasm, a role consistent with data presented in this report. LcrE blocks the secretory machinery from the outside as previously proposed (13, 47) . It is more stringently required for secretion blockage than is LcrG, as an LcrE Ϫ mutant is strongly constitutive for secretion (31, 42) , whereas an LcrG Ϫ mutant varies from being strongly constitutive (42) to leaky (having a partial blockage of secretion in the presence of Ca 2ϩ [31] ). The blocking of secretion by LcrG and LcrE maintains the putative LCR repressor (as well as Yops and LcrV) inside the cell and thereby prevents maximal induction of the LCR. Our results suggest that even in the presence of Ca 2ϩ the majority of LcrG can associate with LcrV, and we postulate that noncomplexed LcrG is critical for determining whether secretion will be fully blocked. Removal of Ca 2ϩ from the medium or contact with eukaryotic cells is sensed by LcrE, perhaps allowing release of the secretion system-associated LcrG and some secretion of Yops and of the LCR repressor. A decrease in intracellular concentration of the LCR repressor then allows increased expression of LCRregulated genes, which include lcrV. The increased levels of LcrV then cause a stronger unblocking of secretion by titrating the remaining LcrG. Hence, LcrV counteracts LcrG's negative regulatory role. The net effect of removing the secretion blocks by both LcrE and LcrG leads to the full induction of the LCR seen in vitro and provides LcrV in excess of LcrG to be secreted and function as an antihost protein. We realize that this model presents only part of the mechanism for regulating the activity of the Yop secretion system. We do not yet have the complete picture for how the signalling through LcrE affects LcrG.
This model incorporates a better picture for the localization and likely site of action for LcrG and LcrV that developed from our localization experiments. Our findings show that in the absence of Ca 2ϩ , LcrG is primarily located in the cytosol, with smaller amounts being found associated with membranes and the culture supernatant. We previously showed that the release of LcrG into the supernatant required the Yop secretion system (42) . It is possible that some LcrG is transported as the LcrG-LcrV complex, perhaps as part of the mechanism for unblocking the secretion system, and our data do not rule this out (Fig. 5) ; however, as this appears to be the minority of the LcrG or cross-linkable LcrG-LcrV complex, we are reluctant , LcrG serves to block the Yop secretion mechanism in the cytoplasm and LcrE blocks secretion at the cell surface. The secretion blockage keeps the putative LCR repressor in the cell, resulting in repression of LCR-regulated operons. In the absence of Ca 2ϩ and in vivo when the bacteria contact a eukaryotic cell, LcrE is released and relieves the secretion block at the cell surface; this allows secretion of some LCR repressor, which allows induction of LCR operons, including lcrV. The increase in LcrV levels titrates LcrG away from the secretion mechanism by forming the LcrG-LcrV complex in the cytoplasm. This removal of the inner secretion block results in full LCR induction.
to focus on the supernatant as being the major site for the function of either LcrG or the complex. A previous model for LCR regulation placed LcrG at the cell surface along with LcrE because, like LcrE, LcrG was secreted in the absence of Ca 2ϩ , and transcomplementation experiments showed that multicopy lcrG did not relieve the effect of (i.e., did not bypass) an lcrE mutation (42) . Moreover, the similar phenotypes of lcrE and lcrG mutants suggested that they may have similar functions. We still believe that LcrG and LcrE have a similar function; i.e., they both block secretion in the absence of an unblocking signal (e.g., removal of Ca 2ϩ or contact with cells) and they are both necessary (but neither is sufficient) for this function. Evidence and cellular localization implicate LcrE as an environmental sensor, responding to Ca 2ϩ concentration or cell contact (5, 13), whereas LcrG's localization makes this role improbable for LcrG. LcrG may respond to an internal signal, such as an increase in LcrV levels, to unblock secretion from the inner face of the inner membrane. LcrG's interaction with LcrV is compatible with the major site of LcrG's function being in the cytoplasm, because we previously showed that LcrV does not need to be secreted to have its regulatory function (43).
LcrG's interaction with LcrV provides an attractive model for LcrV's regulatory function and represents another new aspect of our updated model. Previously a role for LcrV in secretion was discounted because overexpression of YopM under control of a trc promoter in an lcrV mutant resulted in YopM secretion in medium lacking Ca , showing that LcrV is not necessary for secretion. Our present results showing an interaction of LcrV and LcrG suggest that LcrV does function in the control of secretion: i.e., LcrV removes the LcrG secretion block. The model is consistent with LcrV's previously postulated regulatory role in counteracting negative regulation rather than functioning directly in a positive capacity to increase expression of LCR-regulated proteins. Our model is also consistent with the epistasis of lcrE and lcrG mutations over an lcrV mutation, which indicated that lcrE, lcrG, and lcrV act in a common pathway. It is clear that if LcrV acts to counteract LcrG, then LcrV's function would be irrelevant in an LcrG Ϫ mutant. Similarly, if LcrV is necessary for unblocking secretion, then its function would be irrelevant in an LcrE Ϫ mutant, which is constitutively unblocked for secretion. However, we cannot yet explain why YopM was secreted in an lcrV mutant that we would predict to be blocked in secretion. Possibly, overexpression of Yops (such as YopM) by a heterologous promoter coupled to destabilization of the secretion machinery via loss of LcrE's blocking function in the absence of Ca 2ϩ results in displacement of LcrG from the secretion machinery by the high levels of secretion substrate (i.e., YopM).
For our model to work, the levels of LcrG and LcrV would have to be independently controlled under some circumstances either through transcriptional or posttranscriptional mechanisms. Primer extension data show that the lcrV transcript begins immediately upstream of lcrG (33) , and Northern analysis of a series of Yersinia strains having insertion mutations indicated that the V-antigen operon continues downstream through lcrH and yopBD, comprising the lcrGVHyopBD operon (3, 22) . However, it has not been rigorously proven that LcrG and LcrV are translated from a single transcript. The 5Ј end found for lcrV occurs downstream of the proposed ribosomebinding site for lcrG, raising the possibility that LcrG is not made from this transcript. Perhaps LcrG is made from a transcript that starts upstream of lcrD and encompasses lcrDRG. This would result in overlapping transcripts, lcrDRG and lcrGVHyopBD. Our original Mu dI1 (Ap r lac) insertion in lcrG that we found to be polar on lcrV and lcrH (27) could have exerted its polarity because of this overlap. These observations support the idea that lcrG and lcrV levels could be regulated separately at the transcriptional level, and a posttranscriptional mechanism of controlling LcrG and LcrV levels does not need to be invoked.
While determining the localization of LcrG, we found easily detectable amounts of LcrV and at least two Yops in the periplasmic fraction in both the presence and absence of Ca 2ϩ . One primary antibody we used to detect Yops in some of our immunoblots recognizes most of the Yersinia secreted proteins, and it revealed that only a subset of LCR-associated proteins appeared to be released into the periplasm (data not shown).
In other immunoblots where we examined periplasmic fractions with antibodies specific to YopE, YopH, YopM, or LcrE (YopN), we could detect YopE and LcrE but not YopH or YopM (however, LcrE was not released by the spheroplasting procedure; data not shown). Evidence shows that a subset of E. coli cytoplasmic proteins is released into periplasmic fractions by osmotic shock but not by formation of spheroplasts (11); this behavior is interpreted as indicative of a peripheral membrane association for the released proteins. In contrast, we can release some LCR proteins by both osmotic shock and formation of spheroplasts; this behavior has been interpreted as indicative of periplasmic localization. Finding some LCR proteins but not all in periplasmic fractions (prepared by two different methods) is interesting, as Yops and LcrV are secreted by a type III secretion mechanism (39) for which there is no evidence of a periplasmic intermediate in the secretion process. Our results must be interpreted with caution: the data show that either the cytosolic compartment or the secretion pathway used by these LCR proteins is accessible by osmotic shock and spheroplast formation. Future study will be required to determine the basis for this release and the apparent selectivity of it.
This study has enlarged our picture of the type III secretion mechanism that functions to secrete Yops in Yersinia. This secretion mechanism was already known to be environmentally regulated in its activity by proteins, LcrG and LcrE, that are themselves secreted by this mechanism. The Yersinia type III mechanism is apparently regulated both from within and without by specialized secretion substrates. These may represent a novel class of environmentally responsive mobile regulator that modulates secretion system activity. Moreover, by placing LcrV's regulatory role at the level of secretion, we can now attribute a role in Yop secretion to every member of the complex lcrGVHyopBD operon: LcrG and LcrV as discussed above, LcrH as the specific Yop chaperone (SycD) for YopD and perhaps also YopB (49) , and YopB and YopD as postsecretion partitioning proteins that function in the translocation of Yops into a eukaryotic cell (5, 37) . lcrGVHyopBD is now a fifth large operon necessary for the fully functional, environmentally modulated Yersinia Yops secretion mechanism. The lcrGVHyopBD operon specifies secretion-regulatory proteins and ones that direct the final destination of the secreted proteins. It will be interesting to find out how conserved these functions are in the type III secretion systems of other pathogens.
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